Jounce Therapeutics (NASDAQ: JNCE) reported Q2 EPS of ($0.14), versus ($0.11) reported last year. Revenue for the quarter came in at $19.38 million versus the consensus estimate of $12.91 million.

For earnings history and earnings-related data on Jounce Therapeutics (JNCE) click here.